AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 9,535.45
+73.60 (0.78%)
At close: Oct 31, 2025
AstraZeneca Pharma India Company Description
AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, markets, and trades in pharmaceutical products in India and internationally.
It provides medicines for cardiovascular, renal, metabolic, and immunological conditions; oncology medicines under the TAGRISSO, Lynparza, ENHERTU, IMFINZI, and Zoladex brand names; rare diseases medicines under the Koselugo brand name; and respiratory medicines under the Symbicort and Fasenra brand names.
The company also offers medicines for diabetes; and clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India.
AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.
AstraZeneca Pharma India Limited
| Country | India |
| Founded | 1979 |
| Industry | Pharmaceutical Preparations |
| Employees | 802 |
| CEO | Praveen Akkinepally |
Contact Details
Address: Manyata Embassy Business Park Bengaluru, 560045 India | |
| Phone | 91 80 6774 8000 |
| Website | astrazeneca.in |
Stock Details
| Ticker Symbol | 506820 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Praveen Akkinepally | Chief Executive Officer |
| Bhavana Agrawal | Chief Financial Officer |